# Erythrodiol in Pomace Olive Oil as a Protective Agent Against Atherosclerosis

> **NCT07422051** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Spanish National Research Council** · enrollment: 22 (estimated)

## Conditions studied

- Atherosclerosis Cardiovascular Disease

## Interventions

- **OTHER:** Low erythrodiol dose
- **OTHER:** Medium erythrodiol dose
- **OTHER:** High erythrodiol dose

## Key facts

- **NCT ID:** NCT07422051
- **Lead sponsor:** Spanish National Research Council
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-21
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-12-30
- **Target enrollment:** 22 (ESTIMATED)
- **Last updated:** 2026-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07422051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07422051, "Erythrodiol in Pomace Olive Oil as a Protective Agent Against Atherosclerosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07422051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*